Status:
UNKNOWN
Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborating Sponsors:
Sun Yat-sen University
First People's Hospital of Foshan
Conditions:
Breast Neoplasm Female
Surgery
Eligibility:
FEMALE
18-75 years
Brief Summary
Current guidelines lack definitive evidences about the relative benefits of locoregional surgery for the primary tumor in de novo stage IV breast cancer. The aim of this study (SYSBTC-001) was to inve...
Eligibility Criteria
Inclusion
- Operable stage IV breast cancer patients,whose primary lesion is invasive breast cancer confirmed by pathology, and metastases can be confirmed by pathology or imageology examination.
- ECOG-PS 0-2.
- Bone marrow, liver and kidney should be fully functional.
- Patients received the locoregional surgery of the primary tumor in de novo in our center, or didn't received the locoregional surgery of the primary tumor in de novo.
- For the patient who accepted systematic treatment before operation, the systematic treatment must be administered within a year since diagnosed.
Exclusion
- Accompanied with other primary malignant tumors.
- Patients who can't plan for follow-up effectively and regularly.
- Multiple liver metastasis and ALT/AST four times higher than normal at patients' first diagnosis.
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
358 Patients enrolled
Trial Details
Trial ID
NCT04456855
Start Date
September 1 2019
End Date
July 30 2021
Last Update
July 7 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
First People's Hospital of Foshan
Foshan, Guangdong, China, 528000
2
Sun Yat-Sen Memorial Hospital of Sun Yat-sen
Guangzhou, Guangdong, China, 510120
3
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510120